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Food for thought: autophagic
vacuolar myopathies
E-M Strehle
Most paediatricians are familiar with the
terms lysosomal storage disorders (LSDs)
and neuromuscular disorders (NMDs),
and these disease entities seem to have
little in common. Here, I am giving a
synopsis of autophagic vacuolar myopa-
thies (AVMs), a relatively new group of
diseases at the interface between LSDs
and NMDs.1 2 AVMs (lysosomal myopa-
thies) are characterised by the accumula-
tion of abnormal lysosomes in muscle
fibres resulting in specific clinical signs
and symptoms.
The term ‘‘autophagy’’ is derived from
the Greek words ‘‘autos’’ and ‘‘phago’’
meaning ‘‘self-eating’’. Autophagy takes
place in the lysosomes and refers to the
process of breaking down cellular compo-
nents and expelling the products back
into the cytoplasm. Over the last few
years this phenomenon has increasingly
attracted the attention of scientists and
doctors as it also has implications for
ageing, cancer, infection, cardiovascular
disease and neurodegenerative disease.3
LYSOSOMAL STORAGE DISORDERS
LSDs are a group of approximately 50
predominantly autosomal recessive dis-
eases caused by a malfunctioning lysoso-
mal protein. The defective protein can be
a lysosomal enzyme, a lysosomal trans-
porter or a membrane protein, which
leads to accumulation of biological sub-
strates and cell dysfunction. Central
nervous system, skeleton, liver and spleen
are frequently involved. The combined
prevalence of LSDs is 1 in 7700.4 5 Enzyme
assays are currently the gold standard for
diagnostic testing. Several successful stra-
tegies have been developed to treat
patients with specific lysosomal storage
diseases. Allogeneic bone marrow trans-
plantation has been used, among others,
in mucopolysaccharidosis (MPS) types I
and II. Intravenous enzyme replacement
therapy (ERT) is available for MPS I
and IV, Gaucher disease type I (GD I),
Fabry disease and Pompe disease. More
recently, substrate inhibition therapy
with miglustat has been approved for GD
I and Niemann-Pick disease type C (NPC).
LSDs with central nervous system involve-
ment pose a particular challenge due to
difficulties in transporting the deficient
enzyme into brain cells.6
NEUROMUSCULAR DISORDERS
Inherited NMDs, on the other hand,
affect 1 in 3500 of the world population,
and their mode of transmission can be
recessive, dominant or X-linked.7
Duchenne muscular dystrophy (DMD)
has the highest incidence among geneti-
cally transmitted muscle diseases, fol-
lowed by myotonic dystrophy and
facioscapulohumeral muscular dystrophy.
NMDs in children usually present with
muscle weakness and wasting, and gross
motor delay. A diagnosis can often be
made through a blood test and identifica-
tion of the causative gene mutation. If
there is any doubt, a muscle biopsy should
be performed. Treatment is mainly sup-
portive, but oral steroids and angiotensin-
converting enzyme (ACE) inhibitors have
proven to be beneficial in patients with
DMD. A new treatment strategy is the
attempt to change the Duchenne pheno-
type into the milder Becker phenotype
through morpholino-mediated exon skip-
ping.8 The Duchenne phenotype is caused
by out-of-frame mutations in the dystro-
phin gene resulting in the absence of the
muscle protein dystrophin. In Becker mus-
cular dystrophy the amount of dystrophin
is reduced due to in-frame mutations.
Morpholino molecules (antisense oligonu-
cleotides (AONs)) consist of approximately
25 bases attached to six-membered mor-
pholino rings. AONs can block a mutated
exon in the dystrophin gene thus enabling
the remaining intact exons to produce
some functioning protein.
ROLE OF LYSOSOME
Lysosomes originate from the rough
endoplasmic reticulum and the trans-
Golgi network, and act as a recycling
system for eukaryotic cells. They contain
hydrolytic enzymes and have an acidic
pH which is maintained by a vacuolar
H+-ATPase (V-ATPase). Most of these
hydrolases (except b-glucosidase) carry a
mannose-6-phosphate (M6P) marker
which targets them to the lysosomes
during their assembly. Macromolecules
such as carbohydrates, proteins, lipids
and DNA are degraded in the lysosomal
vacuoles and transported back into the
cytoplasm for recycling. There are three
main types of cellular digestion, and
lysosomes are central to each of them.
Phagocytosis refers to the process of
surrounding large food particles or bac-
teria with a segment of the cell membrane
resulting in a phagosome (fig 1).
Pinocytosis is a mechanism similar to
phagocytosis and involves cellular inges-
tion of solute material. During autophagy,
vacuoles derived from the endoplasmic
reticulum are formed around cellular
organelles, for example, aged mitochon-
dria. These vacuoles have been named
autophagosomes or autophagic vacuoles.
Autophagy can be divided into macro-
autophagy and microautophagy (fig 1),
where waste products are taken up by the
lysosome from the cytoplasm directly.
The third mechanism is called receptor-
mediated endocytosis, whereby an area of
the cell membrane containing receptors
and ligands is absorbed into the cell
resulting in an endosome (fig 1). When
phagosome, autophagosome and endo-
some fuse with a lysosome, the catalytic
process can begin.9 10
LYSOSOMES AND MYOPATHY
Lysosomes are barely visible in healthy
muscle fibres on electron microscopy but
become more prominent in patients with
LSDs. So far, two true LSDs associated
with myopathy have been identified.
Acid maltase deficiency is a glycogen
storage disease (GSD II) characterised by
hypotonia, progressive muscle weakness
and cardiomyopathy. It can be divided into
a severe infantile type (Pompe disease), an
intermediate and an adult type. Pompe
disease was first described in 1932.11 On
light microscopy large glycogen-filled
vacuoles (autophagosomes) can be identi-
fied in muscle fibres of affected patients.12
Initial reports of intravenous treatment
with the missing enzyme alpha-glucosidase
are promising.13 However, exogenous
enzyme substitution can induce the pro-
duction of neutralising antibodies, and
additional treatment with immunosuppres-
sant drugs may be required.14
In 1981, Danon et al described two
young, unrelated males with muscle
weakness, hypertrophic cardiomyopathy
and learning difficulties; they both died at
the age of 17 years.15 Muscle biopsy in
these patients was reminiscent of GSD II
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but the autophagosomes were smaller and
denser. Alpha-glucosidase activity was
within the normal range. Further studies
revealed that Danon disease (OMIM
300257) is caused by mutations in the
LAMP2 gene on Xq24 which encodes the
lysosome-associated membrane proteins
2a, 2b and 2c.16 They have multiple
functions which are not fully understood.17
Manifesting female carriers of this X-linked
condition are affected to a milder degree.
One patient with Danon disease from Italy
has received a heart transplant, which is
currently the only treatment available, and
survived more than 5 years.18
MEAX AND MAVIO
X-linked myopathy with excessive auto-
phagy (MEAX, OMIM 310440) shows a
similar histological picture as Danon
disease (autophagic vacuoles with sarco-
lemmal features) but LAMP2 is present in
the lysosomal membrane. Furthermore,
the complement membrane attack com-
plex C5b-C9 can be detected in affected
muscle fibres. Patients with MEAX have a
slowly progressive muscle weakness but
no cardiac involvement. The gene locus
for this disorder has been assigned to
Xq28.19 MAVIO (infantile onset autopha-
gic vacuolar myopathy, OMIM 609500)
has been reported in two infants with
abnormal muscle glycogen storage and
severe cardiomyopathy. Histochemical
analysis suggested that these cases were
on the same spectrum as MEAX.20 In both
conditions the underlying protein defect is
unknown.
MYOPATHIES WITH RIMMED VACUOLES
The last, rather heterogeneous group to be
considered, are the myopathies associated
with rimmed vacuoles. Rimmed vacuoles
are aggregates of autophagosomes found
predominantly in atrophic muscle fibres.
They contain b-amyloid and various other
proteins, for example, cathepsins. The
focus here will be on Nonaka myopathy
or distal myopathy with rimmed vacuoles
(DMRV, OMIM 605820), and on auto-
somal recessive inclusion body myopathy
(IBM2, OMIM 600737). DMRV is a
relatively fast progressing muscular dys-
trophy that starts in early adulthood and
affects the distal muscles. The disease is
more common in Japan and has an
autosomal recessive mode of inheritance.21
IBM2 was first described in Jewish
families living in the Middle East. It is
characterised by onset in the third decade
of life and rapidly advancing proximal and
distal muscle weakness. Interestingly,
there is sparing of the quadriceps muscle.22
Both disorders are caused by mutations in
the GNE gene on chromosome 9p12-9p11
(OMIM 603824). GNE encodes uridine
diphosphate N-acetylglucosamine 2-epi-
merase/N-acetylmannosaminekinase,which
is the rate-limiting enzyme in the biosynth-
esis of sialic acid (N-acetylneuraminic acid,
NeuAc). GNEmutations are also the cause
of sialuria (OMIM 269921) where they lead
to cytoplasmic accumulation and urinary
excretion of free NeuAc. Patients with
DMRV and IBM2 do not excrete excessive
amounts of sialic acids and, conversely,
patients with sialuria do not show myo-
pathy and rimmed vacuoles. A possible
explanation for this observation is the
existence of two specific isoforms of the
GNE gene. Sialic acids are negatively
charged amino sugars that are found as
components of oligosaccharides, polysac-
charides, glycoproteins and gangliosides.
They occur in low concentrations in many
organisms and have a variety of functions,
for example, preventing the aggregation of
blood cells and increasing the viscosity of
glycoproteins in mucous.23 Recent studies
have demonstrated the importance of
hyposialylation for the pathogenesis of
Nonaka myopathy and inclusion body
myopathy.24
CONCLUSION
Lysosomal myopathies are a small but
important group of inherited myopathies
which add to our understanding of
autophagic processes occurring in the cell
and lysosomes. It is likely that further
subtypes of autophagic vacuolar myopa-
thies will be delineated in the near future.
Gene therapy for these conditions is under
investigation.
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